Blue Pointe Capital Management, LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History
Blue Pointe Capital Management, LLC
- $149 Billion
- Q2 2024
A detailed history of Blue Pointe Capital Management, LLC transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Blue Pointe Capital Management, LLC holds 10,378 shares of RVPH stock, worth $12,764. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,378
Previous 10,378
-0.0%
Holding current value
$12,764
Previous $39.2 Million
66.14%
% of portfolio
0.01%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding RVPH
# of Institutions
40Shares Held
6.88MCall Options Held
256KPut Options Held
77.1K-
Woodline Partners LP San Francisco, CA1.59MShares$1.96 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.24MShares$1.53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$1.26 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.01MShares$1.25 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT505KShares$620,6580.1% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $25.1M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...